Fri, 21 Mar 2014
With equity exposure and low initial-contribution limits, these analyst-vetted names could be a better choice.
StockInvestor editor Paul Larson discusses the importance of investing in companies that can compound their intrinsic values, buying on the cheap, avoiding stop-loss orders, and more.
Over the long run, cheap wide-moat stocks have handily outperformed the market, says Morningstar's Heather Brilliant .
Morningstar's Heather Brilliant details our 10-year track record for stocks , particularly the strong outperformance of 5-star names with competitive advantages.
StockInvestor editor Paul Larson details recent changes to Morningstar's Wide Moat Focus Index, noting how the rally in wide-moat names could have them more fairly priced than lower-quality stocks .
For investors wanting extra yield from real estate, REITs that focus on health-care providers have several advantages in their favor.
Unless a company reports quarterly results that stray wildly from expectations, it's best to keep a long -term view on a stock, according to Morningstar's Heather Brilliant .
Although U.S. markets are high and emerging markets have headwinds, these blue chips are great for investors with long time horizons, says StockInvestor editor Matt Coffina.
It's unlikely we'll see the 6.5% long -run real returns of the past decades, but 4.0%-5.5% returns going forward shouldn't disappoint investors, says StockInvestor editor Matt Coffina.
©2014 Morningstar Advisor. All right reserved.